It looks like advocates of medical marijuana will get their day in court later this year when they argue the therapeutic value of cannabis in an effort to have the federal government reschedule the substance from its current state which is a Schedule I drug which is described as substance that has “a high potential for abuse, have no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug or other substance under medical supervision.” This day has been long awaited by millions of patients and medical marijuana advocates around the country. This will be the first time advocates will have the opportunity to present scientific evidence before federal court. This day could not come at a more perfect time do to the fact that a recent study was published in The Open Neurology Journal by Dr.Igor Grant one of the leading U.S medical marijuana researchers claiming that Marijuana’s Schedule I classification is “not tenable”.
Although it is simply a hearing in front of the Federal Government to consider reclassifying marijuana, this is the right step in marijuana legalization and could be considered progress do to the fact that the federal government is going to be giving advocates the opportunity to present their argument on the medicinal benefits of marijuana and arguments as to why the reclassification of medical marijuana should be considered. This is a step in the right direction and marijuana advocates and people around the country can only hope the federal government considers rescheduling the marijuana substance. Oral arguments are said to begin October 16th.